HerbalGram has grown into one of the world’s most influential herbal medicine journals as it celebrates its 35th anniversary. Founder Mark Blumenthal says he’s certain he made the right decision almost 30 years ago to give the publication away.
The International Olympic Committee (IOC) has made available a reference infographic for athletes and dietary supplement users to help decide whether to take or avoid a supplement.
NutraChampion winner Judy Blatman said she has seen a maturation of the dietary supplement industry in her time at the Council for Responsible Nutrition and sees great potential for the future.
Reaction continues to roll in on the recent Cochrane review that found little evidence supporting the cardiovascular benefits of omega-3s. Experts questioned the underlying assumptions in how the review was put together.
From profiling their ingredient suppliers to setting up codes consumers can look up, supplement brands are using transparency to win over consumer trust.
The founders of New Chapter have severed their relationship with Procter & Gamble because they said “financial pressures to accelerate profits” meant they could no longer in good conscience continue to associate themselves with the brand.
Another study published this year posits multivitamin consumption does not improve cardiovascular outcomes. A supplement industry trade group reminds that they weren’t made for that anyway.
A recent research letter on supplement use among children is innocuous in its main findings but suspect in its offhanded conclusions, CRN’s leader said.
A supplement containing a proprietary hop flower extract from New Zealand is entering the US market, positioned for weight management through appetite control.
Nootropics is an area of the dietary supplement industry burgeoning with new ingredients. But at the ragged fringe of the category are drug-like substances that just won’t go away.
CPG giant The Clorox Company has been growing its footprint in the dietary supplement space through acquisitions. During its recent earnings call, the company’s execs fielded questions concerning the logic behind its most recent purchase.
